Healthy adult
Conditions
Sponsors
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Males and females aged 40 years old or older at the time of informed consent. 2) Subject with discomfort or pain of knee joints. 3) Subjects diagnosed as grade 0 or I according to the Kellgren- Lawrence grade (KL grade). 4) Subjects whose BMI are less than 30. 5) Subjects who can make self-judgment and are voluntarily giving written informed consent.
Exclusion criteria
Exclusion criteria: 1) have a history of and/or contract rheumatoid arthritis, or are suspected to have rheumatoid arthritis by screening tests. 2) Subjects who are judged suffering from knee osteoarthritis by the investigator. 3) with knee artificial joints, etc. 4) take joint related medicines (such as poultices, liniments, and/or analgesics, etc.) three or more times a week. 5) with knee joint diseases such as chronic joint pain, ligament injury, or meniscal injury, or those currently under treatment for such conditions. 6) have a history of and/or contract serious diseases (eg, liver disease, kidney disease, digestive disease, heart disease, respiratory disease, endocrine disease, metabolic disease and/or joint disease). 7) can't stop using drugs and/or supplements affecting joints during the study period. 8) have allergies to ingredients of test foods. 9) are under treatment for or have a history of drug addiction and/or alcoholism. 10) are pregnant or planning to become pregnant or breastfeed during the study period. 11) had participated in other clinical studies (measurement) within the last one month prior to the current study and/or are planning to participate in other clinical studies (measurement) during the current study. 12) are judged as unsuitable for the current study by the investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| JOA score | — |
Secondary
| Measure | Time frame |
|---|---|
| JKOM,J-KOOS,VAS,knee flexion angle | — |
Countries
Japan
Contacts
Public ContactMasanori Numazu
KSO Corporation Clinical Trial Management department
Outcome results
None listed